A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Smart nanomedicine agents for cancer, triggered by pH, glutathione, H2O2, or H2S
2019
International Journal of Nanomedicine
Effective tumor diagnosis and therapy have always been a significant but challenging issue. Although nanomedicine has shown great potential for improving the outcomes of tumor diagnosis and therapy, the nonspecial targeted distribution of nanomedicine agents in the whole body causes a low diagnosis signal-to-noise ratio and a potential risk of systemic toxicity. Recently, the development of smart nanomedicine agents with diagnosis and therapy functions that can only be activated by the tumor
doi:10.2147/ijn.s210116
pmid:31440046
pmcid:PMC6664425
fatcat:4pjpuzjvlzbrzdkomppdwyzmgm